Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors
Editat de Dustin L. Williamsen Limba Engleză Paperback – 15 noi 2020
This book offers a much-needed discussion on the targeting of biofilm-related infections. Chapters include discussions on the impact of biofilm on medical implants, industrial applications, as well as wound and tissue infections. It also offers discussions on regulatory management for industrial sectors and medical environments. Given that there continues to be a paucity of effective antimicrobial products, devices, and coatings in clinical and industrial use that effectively reduce rates of infection or biofilm-related problems, Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors, offers a fresh and much-needed perspective aimed at helping create healthier controlled environments and safer devices.
This comprehensive book is indispensable for industrial and academic translational researchers, device developers, and regulatory experts looking to create more effective antimicrobial products.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1088.03 lei 6-8 săpt. | |
| Springer International Publishing – 15 noi 2020 | 1088.03 lei 6-8 săpt. | |
| Hardback (1) | 1094.80 lei 6-8 săpt. | |
| Springer International Publishing – 15 noi 2019 | 1094.80 lei 6-8 săpt. |
Preț: 1088.03 lei
Preț vechi: 1145.30 lei
-5% Nou
Puncte Express: 1632
Preț estimativ în valută:
208.25€ • 214.61$ • 175.81£
208.25€ • 214.61$ • 175.81£
Carte tipărită la comandă
Livrare economică 03-17 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030306694
ISBN-10: 3030306690
Pagini: 162
Ilustrații: XVII, 162 p. 21 illus., 18 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.26 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030306690
Pagini: 162
Ilustrații: XVII, 162 p. 21 illus., 18 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.26 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Overview and data in biofilm sectors: why targeting biofilms is necessary, Dustin Williams
Impact of biofilms in orthopaedics as they relate to regulatory requirements and needs to be met, David Armbruster, MS, MSE, R&D Group Manager, DePuy Synthes
Clinical problems of biofilm implant-related infection and methods/need to target biofilms in patients, Javad Parvizi, MD, Professor of Orthopaedic Surgery, Rothman Institute at Thomas Jefferson University Hospital
Impact of biofilms in catheter systems and regulatory considerations,
Bryan Haymond, MBA, Product Manager, Bard Access Systems
Potential benefits of targeting biofilms in wound-related and other tissue infections, Garth James, PhD, Associate Research Professor, Center for Biofilm Engineering, Montana State University
Biofilms, prevalence and problems related to injured sold
iers and military healthcare facilities, COL Clinton K. Murray, MD, FACP, FIDSA, Colonel, US ArmyFDA insight into the biofilm problem and regulatory management strategy for medical devices, K. Scott Phillips, PhD, Biofilms Research Group Leader, The US FDA and CDR US Public Health Service
Benefits of standardizing approaches to assessing antimicrobial efficacies against biofilms for industrial applications, Darla Goeres, PhD, Associate Research Professor, Chemical & Biological Engineering, Standards Biofilm Methods Laboratory, Center for Biofilm Engineering, Montana State University
EPA insight in the biofilm problem and regulatory management strategy for industrial sectors, Steve Tomasino, PhD, Senior Scientist, Environmental Protection Agency
Notă biografică
Dustin L. Williams has developed translational animal models of biofilm-related infection to mimic clinical scenarios, such as open fractures, wherein biofilms from natural sources (e.g. soil) may be initial contaminants of a wound site. He is a founding member of three companies that have been launched out of the University of Utah; each focusing on anti-biofilm technologies. In 2016, he became the Director of the Bone and Joint Research Lab located in the Department of Veterans Affairs in Salt Lake City, UT. Dustin and his team manage research programs that span biofilm-related infections, osseointegration, bone pathologies such as heterotopic ossification, and specialize in hard plastic embedment for histological analysis.
Textul de pe ultima copertă
This book offers a much-needed discussion on the targeting of biofilm-related infections. Chapters include discussions on the impact of biofilm on medical implants, industrial applications, as well as wound and tissue infections. It also offers discussions on regulatory management for industrial sectors and medical environments. Given that there continues to be a paucity of effective antimicrobial products, devices, and coatings in clinical and industrial use that effectively reduce rates of infection or biofilm-related problems, Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors, offers a fresh and much-needed perspective aimed at helping create healthier controlled environments and safer devices.
This comprehensive book is indispensable for industrial and academic translational researchers, device developers, and regulatory experts looking to create more effective antimicrobial products.
Caracteristici
Outlines the benefits of targeting biofilm-related infections Provides discussion on creating more effective antimicrobial coatings for medical implants Offers perspective on regulatory management for clinical and industrial environments